Transactions under Novozymes’ stock buyback program

As of May 1, Novozymes has purchased an accumulated 2,073,972 shares with a transaction value of DKK 502.8 million under the stock buyback program Novozymes announced in Company announcement No. 17, 2014 and initiated February 17, 2014.

Under the program, Novozymes will buy back B shares worth up to DKK 2 billion in total during 2014.

 

The following transactions have been made under the program in accordance with the provisions of European Commission Regulation (EC) No. 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation:    

 
Number
 of shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement
1,900,475
 
457,958,601
April 25, 2014
40,000
258.32
10,332,983
April 28, 2014
36,645
258.67
9,479,133
April 29, 2014
35,500
 257.85
9,153,833
April 30, 2014
36,802
257.40
9,472,994
May 1, 2014
24,550
260.63
6,398,347
Total accumulated under the program
2,073,972
 
502,795,891

 

In addition, transactions necessitated by Novozymes’ previously established incentive programs have resulted in a net sale by Novozymes of 97,720 B shares in the period from April 25 to May 1, 2014. The share transactions related to the incentive programs were not part of the Safe Harbour stock buyback program.

 

Following the transactions stated above, Novozymes owns a total of 6,370,614 treasury shares, corresponding to 2.0% of the stock capital. The total number of shares in the company is 319,700,000, including treasury shares.

Contact information
Investor Relations:
 
 
Thomas Bomhoff (DK)
+45 3077 1226
Klaus Sindahl (DK)
+45 5363 0134
Martin Riise (USA)
+1 919 649 2565
Press and media:
 
 
Rene Tronborg (DK)
+45 3077 2274
Frederik Bjoerndal (Europe)
+44 7976138265
Paige Donnelly (USA)
+1 919 218 4501
Meng Lian (China)
+86 136 9923 1164
Henrique Pellini (Brazil)
+55 41 9288 0282
Poonam Kapila (India)
+91 991 082 2339